BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 28
• 29
• 30
• 31

• Policy

  Norlase Receives FDA 510(k) Clearance and CE Mark Approval For ECHO™ Green Pattern Laser

  Norlase, a leading global ophthalmic laser manufacturer developing next-generation laser solutions, announced it has received both FDA 510 clearance and CE Mark approval for the ECHO Green Pattern Laser photocoagulator.

  May 5, 2023

   · 

  3 min read
• BioForest

  Arbele celebrates its 7th anniversary as a clinical-stage immunotherapy biotech and the opening of TibTech, its cancer diagnostics subsidiary

  Arbele, a biotechnology company dedicated to fighting gastrointestinal cancers, celebrates its 7th anniversary and the opening of Tiberias Technology, its accredited lab for cancer screening and in vitro diagnostics, at the Hong Kong Science and Technology Park.

  May 5, 2023

   · 

  1 min read
• Business

  Prostatype Genomics appoints Professor Gerald Andriole as Chief Medical Officer

  Prostatype Genomics AB announced that Professor Gerald Andriole has been appointed as global Chief Medical Officer at Prostatype Genomics.

  May 5, 2023

   · 

  3 min read
• Business

  The Cigna Group Reports Strong First Quarter 2023 Results, Raises 2023 Outlook

  Global health company The Cigna Group reported strong first quarter 2023 results reflecting growth and focused execution across our diversified portfolio of businesses.

  May 5, 2023

   · 

  26 min read
• Genetown

  CENTOGENE to Participate in Upcoming Conferences in May 2023

  Centogene N.V., the essential life science partner for data-driven answers in rare and neurodegenerative diseases, announced its conference schedule for May 2023.

  May 5, 2023

   · 

  5 min read
• Policy

  Chiesi Global Rare Diseases and Protalix BioTherapeutics Announce European Commission Authorization of PRX-102 (pegunigalsidase alfa) for the Treatment of Fabry Disease

  Chiesi Global Rare Diseases and Protalix BioTherapeutics, Inc. announced that the European Commission has granted marketing authorization to PRX-102 in the European Union for the treatment of adult patients with Fabry disease.

  May 5, 2023

   · 

  10 min read
• Business

  Bio-Path Holdings to Announce First Quarter 2023 Financial Results on May 12, 2023

  Bio-Path Holdings, Inc. today announced that it will host a live conference call and audio webcast on Friday, May 12, 2023 at 8:30 a.m. ET to report financial results for the first quarter ended March 31, 2023 and to provide a business overview.

  May 5, 2023

   · 

  1 min read
• Business

  Editas Medicine Announces First Quarter 2023 Results and Business Updates

  Editas Medicine, Inc. (Nasdaq: EDIT), a clinical stage genome editing company, today reported business highlights and financial results for the first quarter 2023.

  May 5, 2023

   · 

  9 min read
• Business

  Ocugen Provides Business Update with First Quarter 2023 Financial Results

  Ocugen, Inc. today reported first quarter 2023 financial results along with a general business update.

  May 5, 2023

   · 

  8 min read
• Business

  Arvinas Reports First Quarter 2023 Financial Results and Provides Corporate Update

  Arvinas, Inc. today reported financial results for the first quarter ended March 31, 2023 and provided a corporate update.

  May 5, 2023

   · 

  17 min read